K-numberK252421
Device nameJLK-NCCT
ApplicantJLK, Inc.
Product codeQAS
Device classClass II
Decision dateMar 24, 2026
DecisionSubstantially Equivalent
Regulation892.2080
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

JLK-NCCT is radiological computer-aided triage and notification software that analyzes non-contrast head CT (NCCT) images using artificial intelligence to detect suspected intracranial hemorrhage (ICH) and large vessel occlusion (LVO) in the internal carotid artery, middle cerebral artery M1, and M2. It sends mobile notifications with compressed preview images to alert clinicians for triage and workflow prioritization, without modifying original images or replacing standard diagnostic methods.

Technological characteristics

Both JLK-NCCT and predicate device (Rapid NCCT Stroke, K222884) use AI/ML algorithms to process DICOM-format NCCT images and generate automated notifications. Key differences: JLK-NCCT expands LVO detection to include MCA-M2 (predicate only covers ICA and MCA-M1), uses mobile-only notifications (predicate supports PACS, email, and mobile), and employs different AI models (JLK-ICH and HAS models versus hypodensity and HVS models). Both serve as notification-only tools operating parallel to standard care.

Test standards cited

The document references ISO 13485 (Design Controls, Nonconforming Product, Corrective and Preventative Action) and DICOM standards for image processing. FDA guidance documents cited include 'Content of Premarket Submissions for Device Software Functions' (June 14, 2023). The special controls standard referenced is 21 CFR 892.2080.

Substantial equivalence argument

JLK-NCCT is substantially equivalent because it has the same intended use as the predicate (triage and notification for ICH and LVO), similar technological architecture (AI/ML-based NCCT analysis with mobile notifications), and comparable clinical performance (78.5% sensitivity, 90.3% specificity for LVO detection; 1.67-minute notification time). The differences in AI algorithms and expanded MCA-M2 detection do not introduce new safety or effectiveness questions, and the ICH component is identical to a previously FDA-cleared device (K243363).

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →